(Medical Xpress) -- An international team of scientists, led by the University of Sydney, has found the molecular structure in the body which functions as our 'shock absorber'.
3.7 / 5 (3) |
3
|
A Massachusetts General Hospital research team has identified factors that contribute to solid stress within tumors, suggesting possible ways to alleviate it, and has developed a simple way to measure such pressures.
not rated yet |
0
|
A transparent cornea is essential for vision, which is why the eye has evolved to nourish the cornea without blood vessels. But for millions of people around the world, diseases of the eye or trauma spur the growth of blood ...
not rated yet |
0
|
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis ...
4.5 / 5 (4) |
2
(Medical Xpress)—Using a technique performed at Johns Hopkins but rarely elsewhere, imaging specialists and surgeons have successfully used precision, image-guided technology to glue shut a tangle of abnormal ...
5 / 5 (1) |
0
(Medical Xpress) -- Every year, more than 200,000 people in the U.S. are diagnosed with Wet Age-Related Macular Degeneration, a leading cause of blindness in Americans age 60 or older. There is no known cure ...
5 / 5 (3) |
0
(Medical Xpress)—A new drug developed by researchers from Flinders University, in partnership with collaborators in Melbourne, could hold the key to better treatment of some blinding eye diseases.
not rated yet |
0
The primary treatment for wet macular degeneration, a chronic eye condition that causes vision loss, is effective even if patients have macular traction problems, a Mayo Clinic study shows. The findings will be presented ...
not rated yet |
0
(Medical Xpress)—For most of their natural lives, red blood cells hide safely under the radar of the body's immune system, thanks to a cloak of "don't eat me" protein called CD47. Ching-An Peng of Michigan ...
not rated yet |
0
Diabetes is the leading cause of new cases of blindness among adults 20 to 74 years old. Dr. Michael Grodin, co-director of retinal services and director of clinical research at Katzen Eye Group, with locations around Baltimore, ...
not rated yet |
0
A potential breakthrough in treating late-stage ovarian cancer has come from University of Guelph researchers who have discovered a peptide that shrinks advanced tumours and improves survival rates for this deadly but often ...
not rated yet |
0
At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although ...
not rated yet |
1
